Does RANIBIZUMAB Cause Intraocular pressure increased? 253 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 253 reports of Intraocular pressure increased have been filed in association with RANIBIZUMAB (CIMERLI). This represents 1.7% of all adverse event reports for RANIBIZUMAB.
253
Reports of Intraocular pressure increased with RANIBIZUMAB
1.7%
of all RANIBIZUMAB reports
4
Deaths
33
Hospitalizations
How Dangerous Is Intraocular pressure increased From RANIBIZUMAB?
Of the 253 reports, 4 (1.6%) resulted in death, 33 (13.0%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Intraocular pressure increased Listed in the Official Label?
Yes, Intraocular pressure increased is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Intraocular pressure increased?
AFLIBERCEPT (690)
LATANOPROST (579)
DIFLUPREDNATE (478)
BIMATOPROST (468)
ADALIMUMAB (411)
DEXAMETHASONE (408)
BRIMONIDINE (367)
TRAVOPROST (335)
PREDNISOLONE (314)
TIMOLOL (231)
Which RANIBIZUMAB Alternatives Have Lower Intraocular pressure increased Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE